Urinary N-acetyl-β-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis

被引:18
|
作者
Erdener, D [1 ]
Aksu, K
Biçer, I
Doganavsargil, E
Kutay, FZ
机构
[1] Ege Univ Sch Med, Dept Clin Biochem, TR-35100 Izmir, Turkey
[2] Ege Univ Sch Med, Dept Rheumatol, Izmir, Turkey
[3] Ege Univ Sch Med, Dept Biochem, Izmir, Turkey
关键词
N-acetyl-beta-D-glucosaminidase; proteinuria; lupus nephritis; rheumatoid arthritis;
D O I
10.1002/jcla.20073
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Increased activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) can be used as an early indicator of damage to the tubular epithelium. Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease. Nephritis is known as the most serious complication of SLE and the strongest predictor of poor outcome. In this study urinary NAG excretion was investigated in 24 SLE patients with normal renal function (serum creatinine <= 1.2 mg/dL) and the results were compared with those from 26 untreated patients with rheumatoid arthritis (RA) and 27 healthy controls. The SLE patients were divided into two groups according to their urinary total protein levels: group A consisted of 16 patients with <= 3.5 g/day proteinuria, and group B consisted of eight patients with nephrotic-range proteinuria (>3.5 g/day). Serum and urinary creatinine, total urinary protein levels, and urinary NAG excretion were measured in patients with SLE and RA. In addition, serum C3 and C4 levels were determined in the SLE patients. Renal biopsies were performed in all of the SLE patients. Glomerular lesions were classified according to WHO criteria for lupus nephritis (LN) I-V. The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was used to assess disease activity. Urinary NAG excretion was significantly higher in the SLE groups than in the healthy controls (P<0.001). In urinary NAG excretion there was also significant difference between SLE groups and RA patients (P<0.001). However, there was no significant difference in NAG excretion between the RA and control groups (P=0.062). Urinary NAG excretion was significantly higher (P<0.05) in group B compared to group A. There were no differences in SLEDAI scores, ages, and serum creatinine levels between study groups (P=0.601, P=0.285, P=0.669, respectively). Elevated SLEDAI values and hypocomplementemia were detected more often in younger patients (P<0.010, r=-0.529 and P<0.010, r=-0.569, respectively). There was a strong positive correlation between proteinuria and urinary NAG activity (P<0.001, r=0.759). These results suggest that the determination of urinary NAG activity may be a useful supplement to the routine biochemical analysis performed on the urine in cases of SLE.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 50 条
  • [1] Urinary N-acetyl-β-D-glucosaminidase in rheumatoid arthritis
    M Perwaiz Iqbal
    Azra A Ali
    M Anwar Waqar
    N Mehboobali
    Experimental & Molecular Medicine, 1998, 30 : 165 - 169
  • [2] Renal disease in rheumatoid arthritis.: A study of urinary N-acetyl-β-D-glucosaminidase excretion
    Wiland, P
    Szechinski, J
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 95 - 95
  • [3] Urinary N-acetyl-β-D-glucosaminidase (NAG) activity in the early detection of diabetic nephropathy
    Ali Mohammad Sharifi
    Behnoush Zare
    Morteza Keshavarz
    Mazaher Rahmani
    Bahareh Zaeefy
    Bagher Larijani
    International Journal of Diabetes in Developing Countries, 2015, 35 : 369 - 374
  • [4] Urinary N-acetyl-β-D-glucosaminidase (NAG) activity in the early detection of diabetic nephropathy
    Sharifi, Ali Mohammad
    Zare, Behnoush
    Keshavarz, Morteza
    Rahmani, Mazaher
    Zaeefy, Bahareh
    Larijani, Bagher
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2015, 35 : S369 - S374
  • [5] The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy
    Gluhovschi, Cristina
    Velciov, Silvia
    Kaycsa, Adriana
    Gluhovschi, Gheorghe
    Petrica, Ligia
    Marian, Roxana
    Bozdog, Gheorghe
    Gadalean, Florica
    Bob, Flaviu
    Cioca, Daniel
    Vernic, Corina
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, 34 (01) : 170 - 176
  • [6] Is NAG (N-acetyl-β-D-glucosaminidase) a marker of vesicoureteral reflux (VUR)?
    Cataldi, L
    Pizzini, C
    Vino, M
    Mussap, M
    Plebani, M
    Benini, D
    Fanos, V
    PEDIATRIC RESEARCH, 2000, 47 (04) : 445A - 445A
  • [7] Urinary N-Acetyl-β-d-Glucosaminidase (NAG) Levels and Risk of Cardiovascular Events in Diabetic Patients
    Lou, Weiwei
    Cheng, Qun
    Liang, Yanqiu
    Xia, Ding
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 10495 - 10502
  • [8] Influence of hyperfiltration on the measurement of urinary N-acetyl-β-D-glucosaminidase
    Müller, D
    Sievers, E
    Eggert, P
    PEDIATRIC NEPHROLOGY, 1999, 13 (06) : 519 - 523
  • [9] Influence of hyperfiltration on the measurement of urinary N-acetyl-β-D-glucosaminidase
    D. Müller
    E. Sievers
    P. Eggert
    Pediatric Nephrology, 1999, 13 : 519 - 523
  • [10] Urinary N-acetyl-β-D-glucosaminidase activity in healthy children
    Skálová, S
    Chládek, J
    NEPHROLOGY, 2004, 9 (01) : 19 - 21